orthostatic hypotension in Parkinson's disease
Jump to navigation
Jump to search
Etiology
- multifactorial
- L-dopa & dopamine agonists contribute
Pathology
- involves degeneration of the
Clinical manifestations
- generally occurs in patients with advanced Parkinson's disease
Differential diagnosis
- if it occurs early, consider Parkinson plus syndrome
Management
- reduce antihypertensive agents
- exchange terazosin for tamsulosin in patients with BPH
- liberalize salt intake
- fludrocortisone (Florinef)
- if other measures fail
- 0.1 mg QD generally adequate
- midodrine in moderate-severe cases
- may be added to low-dose Florinef
More general terms
References
- ↑ Bronstein J, In: Intensive Course in Geriatric Medicine & Board Review, Marina Del Ray, CA, Sept 29-Oct 2, 2004